Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from TruScreen Group Ltd. ( (AU:TRU) ) is now available.
TruScreen Group Limited has successfully raised NZ$2.3 million through a share placement, receiving strong support from both new and existing investors, including institutional shareholders from Singapore and Hong Kong. This capital raise, which includes issuing shares and options, is part of a broader strategy to capitalize on significant opportunities in the coming year, reflecting the company’s achievements and growth potential in the medical device industry.
More about TruScreen Group Ltd.
TruScreen Group Limited is a medical device company that specializes in AI-enabled technology for real-time cervical tissue abnormality detection. Their primary product, the TruScreen Ultra, is a cervical cancer screening device that eliminates the need for traditional sampling and processing, offering a more efficient and less invasive option. The device is widely registered and approved for clinical use across multiple countries, including Australia, the UK, China, and others, with a strong distribution network in over 20 countries.
Average Trading Volume: 151,097
Technical Sentiment Signal: Buy
Current Market Cap: A$15.44M
For detailed information about TRU stock, go to TipRanks’ Stock Analysis page.